[{"id":"f3fdd9db-ce7a-465d-92a8-896971593881","acronym":"","url":"https://clinicaltrials.gov/study/NCT03202992","created_at":"2021-01-29T07:14:53.347Z","updated_at":"2024-07-02T16:37:03.145Z","phase":"Phase 1","brief_title":"Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection","source_id_and_acronym":"NCT03202992","lead_sponsor":"Antiva Biosciences","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ABI-1968 topical cream"],"overall_status":"Completed","enrollment":" Enrollment 57","initiation":"Initiation: 08/11/2017","start_date":" 08/11/2017","primary_txt":" Primary completion: 02/04/2019","primary_completion_date":" 02/04/2019","study_txt":" Completion: 02/04/2019","study_completion_date":" 02/04/2019","last_update_posted":"2019-02-07"}]